ORIC PHARMACEUTICALS, INC. Operating Leases, Future Minimum Payments, Due in Three Years
ORIC PHARMACEUTICALS, INC. (ORIC) had Operating Leases, Future Minimum Payments, Due in Three Years of $0 as of 2020-12-31, per its 10-K filed 2021-03-23.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2021-03-23
- 2020-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $0.00.
- 2020-09-30: Operating Leases, Future Minimum Payments, Due in Three Years $686.00K.
- 2020-06-30: Operating Leases, Future Minimum Payments, Due in Three Years $686.00K.
- 2020-03-31: Operating Leases, Future Minimum Payments, Due in Three Years $686.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-23 |
| 2020-09-30 | $686.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $686.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $686.00K 10-Q · filed 2020-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |